AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Understand which index funds are best for IRAs in 2024, with guidance on diversification, costs, and long-term retirement goals.
24,195 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A new $6 billion prize pool is attracting tech giants as they vie for breakthroughs in AI-safe security, cloud resili...
GE Vernova arrives at its July 22 earnings with a $163 billion backlog and raised targets, signaling a strong beat ri...
Mortgage rates sit above 6.6%, yet early 2026 data suggest the housing market still grow. This report breaks down wha...
SpaceX is attracting renewed investor interest as revenue streams expand beyond launches. With Starlink, NASA deals, ...
A high-value delivery went missing from a FedEx facility, valued at nearly $241k. The coins later showed up in pawn s...
A renewed push from the White House to create a Strategic Bitcoin Reserve could reshape how the U.S. views crypto. Th...
AST SpaceMobile has fallen from its highs even after a sizable funding round. This article explains why the fade in s...
Cardano’s NIGHT token tumbled to an all-time low following a large bridge-related token movement. The Midnight Founda...
Two tech giants are racing to power AI at scale, pouring hundreds of billions into data centers and power. The big qu...
Senate Democrats allege the White House granted tariff exemptions to firms tied to donors, sparking a bipartisan push...
A top analyst argues that broad tariffs act like a dirty tax, risking higher debt costs as the U.S. grapples with a $...